Treatment with pegylated interferon and ribavirin in a patient with fibrosing cholestatic hepatitis due to recurrent hepatitis C after liver transplantation / 대한간학회지
The Korean Journal of Hepatology
;
: 519-524, 2008.
Article
in Korean
| WPRIM
| ID: wpr-147555
ABSTRACT
Fibrosing cholestatic hepatitis (FCH) is the most devastating manifestation of recurrent hepatitis C in transplant recipients with hepatitis C virus (HCV), possibly leading to death or retransplantation. Although FCH was first described as a complication of hepatitis B, this manifestation has been well documented in association with HCV in the setting of liver transplantation, bone marrow transplantation, heart transplantation, and end-stage human immunodeficiency virus infection. We report the clinical course and antiviral response in a patient with FCH due to recurrent hepatitis C after cadaveric liver transplantation who was treated with pegylated interferon alpha-2a and ribavirin.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Antiviral Agents
/
Polyethylene Glycols
/
Recurrence
/
Ribavirin
/
RNA, Viral
/
Tomography, X-Ray Computed
/
Cholestasis, Intrahepatic
/
Liver Transplantation
/
Combined Modality Therapy
/
Hepacivirus
Limits:
Humans
/
Male
Language:
Korean
Journal:
The Korean Journal of Hepatology
Year:
2008
Type:
Article
Similar
MEDLINE
...
LILACS
LIS